X-Linked Combined Immunodeficiency Diseases

Explore clinical trials studying X-Linked Combined Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

17 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

X-Linked Combined Immunodeficiency Diseases trial results

Completed

Human Placental-Derived Stem Cell Transplantation

NCT01586455

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adrenal Gland Diseases, +84 more
Locations: Children's Hospital Colorado Denver, Colorado, United States

New York Medical College Valhalla, New York, United States

University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

Diversion-p64 Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device

NCT02600364

Conditions: Aneurysm, Brain Diseases, Cardiovascular Diseases, +16 more
Locations: Clínica La Sagrada Familia Buenos Aires, Argentina

Ziekenhuis Oost-Limburg Genk, Belgium

St. Ivan Rilski Hospital Sofia, Bulgaria

Groupe Hospitalier Pellegrin Bordeaux, France

View all 26 locations

View Trial Details

Completed

Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant

NCT00008450

Conditions: Adenosine Deaminase Deficiency, Autosomal Recessive Disorder, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +17 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)

NCT00028236

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID

NCT00006335

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Developing Newborn Screening for Infants With Primary Immunodeficiency

NCT00113464

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +9 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Active, Not Recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions: 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations: RTI International Research Triangle Park, North Carolina, United States

View Trial Details

X-Linked Combined Immunodeficiency Diseases

X-Linked Combined Immunodeficiency Diseases trial results

Human Placental-Derived Stem Cell Transplantation

Diversion-p64 Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device

Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant

Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)

Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID

Developing Newborn Screening for Infants With Primary Immunodeficiency

Early Check: Expanded Screening in Newborns

Related conditions